Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT: Fitness and Inflammation in Breast Cancer Survivors
NCT02415387Phase 1Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jan 2014
- Primary completion
- Apr 2021
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of salmonella typhi capsular polysaccharide vaccine in typhoid fever (2 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoint: AUC Change in Level of IL-6 at 8 hours. Started Jan 2014; status: completed.
02
Drugs
salmonella typhi capsular polysaccharide vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT02415387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02415387.